Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lymphoma, T-Cell, Cutaneous × mogamulizumab × Clear all

Phase

Status

Sponsor Class

OTHER 5 INDUSTRY 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

mogamulizumab 1 liposomal amphotericin B 1 imetelstat 1 atezolizumab 1 Watchful Waiting 1 Vorinostat 1 Vincristine 1 Vancomycin 1 VAP-cyclo protocol 1 Tazobactam 1 Radiotherapy 1 Prednisone 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Nicotine 1 Moxifloxacin 1 Morphine 1 Methoxsalen 1 Methotrexate 1 Lenalidomide 1 Introns 1 Interferon alpha-2 1 Etoposide 1 EPOCH protocol 1 Doxorubicin 1 Dextromethorphan 1 Cyclophosphamide 1 Clorazepate Dipotassium 1 Ciprofloxacin 1 Caspofungin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡